Bristol Myers Squibb (CELG-RI) Notes Payables (2009 - 2016)

Bristol Myers Squibb (CELG-RI) has 8 years of Notes Payables data on file, last reported at $155.0 million in Q2 2016.

• Notes Payables for Q2 2016 came in at $155.0 million, down 79.47% year-over-year; the trailing twelve-month figure through Jun 2016 was $155.0 million (down 79.47% YoY), and the FY2015 annual result was $139.0 million, down 76.44% from the prior year.
• Notes Payables climbed to $155.0 million in Q2 2016 per CELG-RI's latest filing, from $106.0 million in the prior quarter.
• Over five years, Notes Payables peaked at $1.4 billion in Q1 2013 and troughed at $106.0 million in Q1 2016.
• A 5-year average of $494.3 million and a median of $383.0 million in 2014 frame the typical range for Notes Payables.
• The sharpest annual moves came in 2013 and 2014: Notes Payables surged 846.21% in 2013, then tumbled 79.52% in 2014.
• A 5-year view of Notes Payables shows it stood at $826.0 million in 2012, then sank by 56.54% to $359.0 million in 2013, then surged by 64.35% to $590.0 million in 2014, then slumped by 76.44% to $139.0 million in 2015, then climbed by 11.51% to $155.0 million in 2016.
• Business Quant data shows CELG-RI's Notes Payables at $155.0 million in Q2 2016, $106.0 million in Q1 2016, and $139.0 million in Q4 2015.